nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.059	0.0768	CcSEcCtD
Goserelin—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0239	0.0311	CcSEcCtD
Goserelin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0242	CcSEcCtD
Goserelin—LHCGR—G alpha (s) signalling events—PTH—nephrolithiasis	0.0165	0.0781	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CHRM3—nephrolithiasis	0.0155	0.0732	CbGpPWpGaD
Goserelin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0188	CcSEcCtD
Goserelin—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0188	CcSEcCtD
Goserelin—Gout—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0187	CcSEcCtD
Goserelin—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0184	CcSEcCtD
Goserelin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.014	0.0182	CcSEcCtD
Goserelin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0178	CcSEcCtD
Goserelin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0158	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—DGKH—nephrolithiasis	0.012	0.0569	CbGpPWpGaD
Goserelin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0146	CcSEcCtD
Goserelin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0146	CcSEcCtD
Goserelin—Swelling—Hydrochlorothiazide—nephrolithiasis	0.011	0.0143	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0108	0.0509	CbGpPWpGaD
Goserelin—LHCGR—renal system—nephrolithiasis	0.0106	0.508	CbGeAlD
Goserelin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0136	CcSEcCtD
Goserelin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0135	CcSEcCtD
Goserelin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0135	CcSEcCtD
Goserelin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0134	CcSEcCtD
Goserelin—LHCGR—kidney—nephrolithiasis	0.0102	0.491	CbGeAlD
Goserelin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0133	CcSEcCtD
Goserelin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0133	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.01	0.0475	CbGpPWpGaD
Goserelin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00964	0.0126	CcSEcCtD
Goserelin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00956	0.0125	CcSEcCtD
Goserelin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00956	0.0125	CcSEcCtD
Goserelin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00921	0.012	CcSEcCtD
Goserelin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00891	0.0116	CcSEcCtD
Goserelin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00878	0.0114	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0087	0.0411	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0086	0.0407	CbGpPWpGaD
Goserelin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0109	CcSEcCtD
Goserelin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00818	0.0107	CcSEcCtD
Goserelin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0102	CcSEcCtD
Goserelin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00781	0.0102	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00778	0.0368	CbGpPWpGaD
Goserelin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00776	0.0101	CcSEcCtD
Goserelin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00773	0.0101	CcSEcCtD
Goserelin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00767	0.00998	CcSEcCtD
Goserelin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00764	0.00995	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—RGS14—nephrolithiasis	0.00758	0.0359	CbGpPWpGaD
Goserelin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00758	0.00987	CcSEcCtD
Goserelin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00753	0.00981	CcSEcCtD
Goserelin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00738	0.00961	CcSEcCtD
Goserelin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00736	0.00959	CcSEcCtD
Goserelin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00734	0.00956	CcSEcCtD
Goserelin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0073	0.00951	CcSEcCtD
Goserelin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00948	CcSEcCtD
Goserelin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00935	CcSEcCtD
Goserelin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0093	CcSEcCtD
Goserelin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00706	0.0092	CcSEcCtD
Goserelin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00915	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—RGS14—nephrolithiasis	0.00688	0.0326	CbGpPWpGaD
Goserelin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00674	0.00878	CcSEcCtD
Goserelin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00672	0.00876	CcSEcCtD
Goserelin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00667	0.00869	CcSEcCtD
Goserelin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00863	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CHRM3—nephrolithiasis	0.00655	0.031	CbGpPWpGaD
Goserelin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00782	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—PTH—nephrolithiasis	0.00599	0.0283	CbGpPWpGaD
Goserelin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00774	CcSEcCtD
Goserelin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00762	CcSEcCtD
Goserelin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00751	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00576	0.0272	CbGpPWpGaD
Goserelin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00748	CcSEcCtD
Goserelin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0074	CcSEcCtD
Goserelin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00737	CcSEcCtD
Goserelin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00733	CcSEcCtD
Goserelin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00718	CcSEcCtD
Goserelin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00707	CcSEcCtD
Goserelin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00704	CcSEcCtD
Goserelin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00687	CcSEcCtD
Goserelin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00682	CcSEcCtD
Goserelin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00674	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—DGKH—nephrolithiasis	0.00512	0.0242	CbGpPWpGaD
Goserelin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00511	0.00665	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—RGS14—nephrolithiasis	0.00507	0.024	CbGpPWpGaD
Goserelin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00649	CcSEcCtD
Goserelin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00649	CcSEcCtD
Goserelin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00649	CcSEcCtD
Goserelin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00647	CcSEcCtD
Goserelin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00641	CcSEcCtD
Goserelin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00635	CcSEcCtD
Goserelin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00482	0.00627	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ADCY10—nephrolithiasis	0.00478	0.0226	CbGpPWpGaD
Goserelin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00478	0.00622	CcSEcCtD
Goserelin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00478	0.00622	CcSEcCtD
Goserelin—Shock—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00612	CcSEcCtD
Goserelin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00609	CcSEcCtD
Goserelin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00607	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—DGKH—nephrolithiasis	0.00465	0.022	CbGpPWpGaD
Goserelin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00601	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—RGS14—nephrolithiasis	0.00461	0.0218	CbGpPWpGaD
Goserelin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00593	CcSEcCtD
Goserelin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00581	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CHRM3—nephrolithiasis	0.00439	0.0207	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00567	CcSEcCtD
Goserelin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00563	CcSEcCtD
Goserelin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00559	CcSEcCtD
Goserelin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00555	CcSEcCtD
Goserelin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00553	CcSEcCtD
Goserelin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00548	CcSEcCtD
Goserelin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00541	CcSEcCtD
Goserelin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00536	CcSEcCtD
Goserelin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00532	CcSEcCtD
Goserelin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00532	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RGS14—nephrolithiasis	0.00407	0.0192	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTH—nephrolithiasis	0.00401	0.019	CbGpPWpGaD
Goserelin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00513	CcSEcCtD
Goserelin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00509	CcSEcCtD
Goserelin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00494	CcSEcCtD
Goserelin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00492	CcSEcCtD
Goserelin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00492	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0037	0.0175	CbGpPWpGaD
Goserelin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00458	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—DGKH—nephrolithiasis	0.00343	0.0162	CbGpPWpGaD
Goserelin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00446	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—PTH—nephrolithiasis	0.00339	0.016	CbGpPWpGaD
Goserelin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00338	0.0044	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CHRM3—nephrolithiasis	0.00336	0.0159	CbGpPWpGaD
Goserelin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00426	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ADCY10—nephrolithiasis	0.0032	0.0151	CbGpPWpGaD
Goserelin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00411	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—DGKH—nephrolithiasis	0.00311	0.0147	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTH—nephrolithiasis	0.00307	0.0145	CbGpPWpGaD
Goserelin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00396	CcSEcCtD
Goserelin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00392	CcSEcCtD
Goserelin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00392	CcSEcCtD
Goserelin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0039	CcSEcCtD
Goserelin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00369	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00275	0.013	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DGKH—nephrolithiasis	0.00275	0.013	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RGS14—nephrolithiasis	0.00272	0.0129	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00248	0.0117	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTH—nephrolithiasis	0.00227	0.0107	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CHRM3—nephrolithiasis	0.00225	0.0106	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTH—nephrolithiasis	0.00206	0.00974	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CHRM3—nephrolithiasis	0.00199	0.00939	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00184	0.0087	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DGKH—nephrolithiasis	0.00184	0.0087	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTH—nephrolithiasis	0.00182	0.00859	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CHRM3—nephrolithiasis	0.00133	0.00629	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTH—nephrolithiasis	0.00122	0.00575	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPP1—nephrolithiasis	0.000912	0.00431	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—nephrolithiasis	0.00061	0.00289	CbGpPWpGaD
